Skip to content

Investigation for the treatment option and cost in urological cancers

Investigation for the treatment option and cost in urological cancers - Investigation for the treatment option and cost in urological cancers

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000028544
Enrollment
500
Registered
2017-08-06
Start date
2017-06-02
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urological cancers

Interventions

None listed

Sponsors

Hirosaki University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Urological cancer patients who undergo any therapy

Exclusion criteria

Exclusion criteria: Urological cancer patients who do not undergo any therapy

Design outcomes

Primary

MeasureTime frame
Relationship between the treatment option and medical cost

Secondary

MeasureTime frame
Optimal use of medical budget for suitable candidates

Countries

Japan

Contacts

Public ContactShingo hatakeyama

Hirosaki University School of Medicine Urology

uroyone@hirosaki-u.ac.jp0172395091

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026